Bionic pancreas system successfully controls blood sugar without risk of hypoglycemia
(Massachusetts General Hospital) The bionic pancreas system developed by Boston University investigators proved better than either conventional or sensor-augmented insulin pump therapy at managing blood sugar levels in patients with type 1 diabetes living at home, with no restrictions, in a clinical trial led by a Massachusetts General Hospital physician.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: Boston University | Clinical Trials | Diabetes | Diabetes Type 1 | Endocrinology | Hospitals | Insulin | International Medicine & Public Health | Pancreas